SG Americas Securities LLC Acquires New Position in DaVita Inc. (NYSE:DVA)

SG Americas Securities LLC bought a new position in DaVita Inc. (NYSE:DVA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,528 shares of the company's stock, valued at approximately $846,000.

A number of other hedge funds have also modified their holdings of the stock. Sanctuary Advisors LLC bought a new stake in DaVita during the 4th quarter worth approximately $180,000. CIBC Asset Management Inc raised its stake in DaVita by 1.4% during the 4th quarter. CIBC Asset Management Inc now owns 7,730 shares of the company's stock worth $1,156,000 after buying an additional 109 shares during the period. Venturi Wealth Management LLC raised its stake in DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after buying an additional 152 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in DaVita during the 4th quarter worth $597,000. Finally, Hussman Strategic Advisors Inc. grew its holdings in shares of DaVita by 200.0% in the 4th quarter. Hussman Strategic Advisors Inc. now owns 25,200 shares of the company's stock valued at $3,769,000 after acquiring an additional 16,800 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on DVA shares. Truist Financial decreased their price objective on DaVita from $170.00 to $164.00 and set a "hold" rating for the company in a report on Monday, May 19th. Wall Street Zen upgraded DaVita from a "hold" rating to a "buy" rating in a report on Friday, April 25th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $164.50.

DaVita Stock Down 0.4%

Shares of NYSE DVA traded down $0.59 during trading on Monday, hitting $136.35. The stock had a trading volume of 1,017,080 shares, compared to its average volume of 805,512. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.25 and a quick ratio of 1.20. The company has a market capitalization of $10.29 billion, a PE ratio of 13.51, a PEG ratio of 0.94 and a beta of 1.11. DaVita Inc. has a 12 month low of $131.76 and a 12 month high of $179.60. The firm has a fifty day moving average of $139.55 and a two-hundred day moving average of $149.86.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.25. DaVita had a net margin of 6.63% and a return on equity of 176.11%. The company had revenue of $3.22 billion during the quarter, compared to analyst estimates of $3.22 billion. During the same quarter last year, the business posted $2.26 EPS. DaVita's quarterly revenue was up 5.0% compared to the same quarter last year. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.